Chronic inflammation of tuberculosis

Anas Khalil, Kuan Jen Bai, Shawn Hsiang Yin Chen

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Managing Tuberculosis (TB) infection remains a challenge and there is a need for modern science to infuse new principles. Better use of existing medications, at the stage without effective vaccines and newly developed medications, is a field in urgent need of research effort. This classical infectious disease, in year 2011 alone, actively infected 8.7 million people and 1.4 million people died. TB and human immunodeficiency virus (HIV) HIV co-infection, multidrug-resistant (MDR) as well as extensively drug-resistant (XDR) TB, and clinically significant adverse drug reactions resulting from long-term medication treatment, altogether contributes to complex treatment problems and TB control challenges worldwide. Pharmacogenetics, together with pharmacoepidemiology studies, would help establish better clinical strategies for evaluating, treating, and monitoring tuberculosis patients. Factors affecting the treatment outcome of TB would be an important domain for clinical research. These include reducing patient default from anti-TB treatment, enhancing the adherence of medication administration, improving the cure rate, avoiding TB relapse, and preventing activation of TB infection. Research efforts thus are warranted to investigate the potential risk factors for TB infection from many aspects: comorbidities, social-economic status, health-related behaviors, occupations, use of certain immunosuppressing medications and genetic involvement. For example, monitoring some genetic variations at some loci of the essential liver enzymes, for instance: monitoring the N-acetlytransferase 2 (NAT2), Cytochrome P450 oxidase (CYP2E1), glutathione S-transferases family (GSTs) that metabolizes and detoxifies anti- TB drugs would give good information about these drug responses and their toxicity. Further, this would help to design personalized medicine for TB in the future.

Original languageEnglish
Title of host publicationChronic Inflammation: Causes, Treatment Options and Role in Disease
PublisherNova Science Publishers, Inc.
Pages171-194
Number of pages24
ISBN (Print)9781628080940
Publication statusPublished - 2013

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Chronic inflammation of tuberculosis'. Together they form a unique fingerprint.

  • Cite this

    Khalil, A., Bai, K. J., & Chen, S. H. Y. (2013). Chronic inflammation of tuberculosis. In Chronic Inflammation: Causes, Treatment Options and Role in Disease (pp. 171-194). Nova Science Publishers, Inc..